1. Gladysz, JA, Amini, H, Baranová, Z, Weisbach, N, Gauthier, S, Bhuvanesh, N et al.. Syntheses, Structures, and Spectroscopic Properties of 1,10-Phenanthroline Based Macrocycles threaded by PtC8Pt, PtC12Pt, and PtC16Pt Axles: Metal-capped Rotaxanes as Insulated Molecular Wires. Chemistry. 2019; :. doi: 10.1002/chem.201903927. PubMed PMID:31596000 .
  2. Hadoux, X, Hui, F, Lim, JKH, Masters, CL, Pébay, A, Chevalier, S et al.. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease. Nat Commun. 2019;10 (1):4227. doi: 10.1038/s41467-019-12242-1. PubMed PMID:31530809 PubMed Central PMC6748929.
  3. Shin, J, Rowley, J, Chowdhury, R, Jolicoeur, P, Klein, D, Grova, C et al.. Inferior Longitudinal Fasciculus' Role in Visual Processing and Language Comprehension: A Combined MEG-DTI Study. Front Neurosci. 2019;13 :875. doi: 10.3389/fnins.2019.00875. PubMed PMID:31507359 PubMed Central PMC6716060.
  4. Jia, L, Quan, M, Fu, Y, Zhao, T, Li, Y, Wei, C et al.. Dementia in China: epidemiology, clinical management, and research advances. Lancet Neurol. 2019; :. doi: 10.1016/S1474-4422(19)30290-X. PubMed PMID:31494009 .
  5. Schoemaker, D, Buss, C, Pietrantonio, S, Maunder, L, Freiesleben, SD, Hartmann, J et al.. The hippocampal-to-ventricle ratio (HVR): Presentation of a manual segmentation protocol and preliminary evidence. Neuroimage. 2019;203 :116108. doi: 10.1016/j.neuroimage.2019.116108. PubMed PMID:31472249 .
  6. Anastassiadis, C, Jones, SL, Pruessner, JC. Imaging the pituitary in psychopathologies: a review of in vivo magnetic resonance imaging studies. Brain Struct Funct. 2019;224 (8):2587-2601. doi: 10.1007/s00429-019-01942-5. PubMed PMID:31432271 .
  7. Schifani, C, Pruessner, J, Tseng, HH, Rao, N, Tagore, A, Wilson, AA et al.. Stress-induced cortical dopamine response is altered in subjects at clinical high risk for psychosis using cannabis. Addict Biol. 2019; :e12812. doi: 10.1111/adb.12812. PubMed PMID:31389139 .
  8. Gauthier, S, Tattevin, P, Soulat, L, Bouget, J, Abergel, S, Hascoet, J et al.. Pain intensity and imaging at the initial phase of acute pyelonephritis. Med Mal Infect. 2019; :. doi: 10.1016/j.medmal.2019.07.013. PubMed PMID:31387815 .
  9. Baumeister, D, Peters, E, Pruessner, J, Howes, O, Chadwick, P. The effects of voice content on stress reactivity: A simulation paradigm of auditory verbal hallucinations. Schizophr. Res. 2019; :. doi: 10.1016/j.schres.2019.07.019. PubMed PMID:31377050 .
  10. Martin, CB, Mirsattari, SM, Pruessner, JC, Burneo, JG, Hayman-Abello, B, Köhler, S et al.. Relationship between déjà vu experiences and recognition-memory impairments in temporal-lobe epilepsy. Memory. 2019; :1-11. doi: 10.1080/09658211.2019.1643891. PubMed PMID:31339436 .
  11. Chertkow, H, Borrie, M, Whitehead, V, Black, SE, Feldman, HH, Gauthier, S et al.. The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study. Can J Neurol Sci. 2019;46 (5):499-511. doi: 10.1017/cjn.2019.27. PubMed PMID:31309917 .
  12. Robert, C, Gandon, Y, Peyronnet, B, Gauthier, S, Aubé, C, Paisant, A et al.. Utility of enhanced CT for patients with suspected uncomplicated renal colic and no acute findings on non-enhanced CT. Clin Radiol. 2019;74 (10):813.e11-813.e18. doi: 10.1016/j.crad.2019.06.007. PubMed PMID:31300208 .
  13. Ryu, JC, Zimmer, ER, Rosa-Neto, P, Yoon, SO. Consequences of Metabolic Disruption in Alzheimer's Disease Pathology. Neurotherapeutics. 2019;16 (3):600-610. doi: 10.1007/s13311-019-00755-y. PubMed PMID:31270743 PubMed Central PMC6694332.
  14. Cui, Y, Dai, S, Miao, Z, Zhong, Y, Liu, Y, Liu, L et al.. Reliability and Validity of the Chinese Version of the Mild Behavioral Impairment Checklist for Screening for Alzheimer's Disease. J. Alzheimers Dis. 2019;70 (3):747-756. doi: 10.3233/JAD-190113. PubMed PMID:31256131 .
  15. Therriault, J, Wang, S, Mathotaarachchi, S, Pascoal, TA, Parent, M, Beaudry, T et al.. Rostral-Caudal Hippocampal Functional Convergence Is Reduced Across the Alzheimer's Disease Spectrum. Mol. Neurobiol. 2019; :. doi: 10.1007/s12035-019-01671-0. PubMed PMID:31230260 .
  16. Meyer, PF, Labonté, A, Rosa-Neto, P, Poirier, J, Breitner, JCS, PREVENT‐AD Research Group et al.. No apparent effect of naproxen on CSF markers of innate immune activation. Ann Clin Transl Neurol. 2019;6 (6):1127-1133. doi: 10.1002/acn3.788. PubMed PMID:31211178 PubMed Central PMC6562029.
  17. Miron, J, Picard, C, Lafaille-Magnan, MÉ, Savard, M, Labonté, A, Breitner, J et al.. Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation. Alzheimers Dement. 2019;15 (7):951-960. doi: 10.1016/j.jalz.2019.03.012. PubMed PMID:31175027 .
  18. Pascoal, TA, Mathotaarachchi, S, Kang, MS, Mohaddes, S, Shin, M, Park, AY et al.. Aβ-induced vulnerability propagates via the brain's default mode network. Nat Commun. 2019;10 (1):2353. doi: 10.1038/s41467-019-10217-w. PubMed PMID:31164641 PubMed Central PMC6547716.
  19. Jones, SL, Dufoix, R, Laplante, DP, Elgbeili, G, Patel, R, Chakravarty, MM et al.. Larger Amygdala Volume Mediates the Association Between Prenatal Maternal Stress and Higher Levels of Externalizing Behaviors: Sex Specific Effects in Project Ice Storm. Front Hum Neurosci. 2019;13 :144. doi: 10.3389/fnhum.2019.00144. PubMed PMID:31156408 PubMed Central PMC6528106.
  20. Vrinceanu, T, Esmail, A, Berryman, N, Predovan, D, Vu, TTM, Villalpando, JM et al.. Dance your stress away: comparing the effect of dance/movement training to aerobic exercise training on the cortisol awakening response in healthy older adults. Stress. 2019;22 (6):687-695. doi: 10.1080/10253890.2019.1617690. PubMed PMID:31124397 .
  21. Allenby, C, Falcone, M, Ashare, RL, Cao, W, Bernardo, L, Wileyto, EP et al.. Brain Marker Links Stress and Nicotine Abstinence. Nicotine Tob. Res. 2019; :. doi: 10.1093/ntr/ntz077. PubMed PMID:31120113 .
  22. Liebsch, F, Kulic, L, Teunissen, C, Shobo, A, Ulku, I, Engelschalt, V et al.. Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression. Nat Commun. 2019;10 (1):2240. doi: 10.1038/s41467-019-10152-w. PubMed PMID:31110178 PubMed Central PMC6527709.
  23. Gauthier, S. Aligning direct observation and assessment. Med Educ. 2019;53 (7):642-644. doi: 10.1111/medu.13903. PubMed PMID:31106882 .
  24. Gauthier, S, Alam, J, Fillit, H, Iwatsubo, T, Liu-Seifert, H, Sabbagh, M et al.. Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task Force. J Prev Alzheimers Dis. 2019;6 (3):164-168. doi: 10.14283/jpad.2019.12. PubMed PMID:31062826 .
  25. Bailey, JJ, Kaiser, L, Lindner, S, Wüst, M, Thiel, A, Soucy, JP et al.. First-in-Human Brain Imaging of [18F]TRACK, a PET tracer for Tropomyosin Receptor Kinases. ACS Chem Neurosci. 2019;10 (6):2697-2702. doi: 10.1021/acschemneuro.9b00144. PubMed PMID:31017386 .
  26. Marchand, W, Girardin, MP, Hartmann, H, Gauthier, S, Bergeron, Y. Taxonomy, together with ontogeny and growing conditions, drives needleleaf species' sensitivity to climate in boreal North America. Glob Chang Biol. 2019;25 (8):2793-2809. doi: 10.1111/gcb.14665. PubMed PMID:31012507 .
  27. Lleó, A, Alcolea, D, Martínez-Lage, P, Scheltens, P, Parnetti, L, Poirier, J et al.. Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study. Alzheimers Dement. 2019;15 (6):742-753. doi: 10.1016/j.jalz.2019.01.015. PubMed PMID:30967340 .
  28. Gauthier, S, Gagnon, L, Rochon, A. Users' perspectives on medical assistance in dying for persons with dementia. Int J Geriatr Psychiatry. 2019;34 (7):905. doi: 10.1002/gps.5115. PubMed PMID:30958580 .
  29. Meyer, PF, Tremblay-Mercier, J, Leoutsakos, J, Madjar, C, Lafaille-Maignan, MÉ, Savard, M et al.. INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Neurology. 2019;92 (18):e2070-e2080. doi: 10.1212/WNL.0000000000007232. PubMed PMID:30952794 PubMed Central PMC6512884.
  30. Gagnon, K, Baril, AA, Montplaisir, J, Carrier, J, De Beaumont, L, D'Aragon, C et al.. Disconnection Between Self-Reported and Objective Cognitive Impairment in Obstructive Sleep Apnea. J Clin Sleep Med. 2019;15 (3):409-415. doi: 10.5664/jcsm.7664. PubMed PMID:30853044 PubMed Central PMC6411171.
  31. Su, Y, Flores, S, Wang, G, Hornbeck, RC, Speidel, B, Joseph-Mathurin, N et al.. Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies. Alzheimers Dement (Amst). 2019;11 :180-190. doi: 10.1016/j.dadm.2018.12.008. PubMed PMID:30847382 PubMed Central PMC6389727.
  32. Miranda, A, Kang, MS, Blinder, S, Bouhachi, R, Soucy, JP, Aliaga-Aliaga, A et al.. PET imaging of freely moving interacting rats. Neuroimage. 2019;191 :560-567. doi: 10.1016/j.neuroimage.2019.02.064. PubMed PMID:30831313 .
  33. Liu, J, Wang, Q, Jing, D, Gao, R, Zhang, J, Cui, C et al.. Diagnostic Approach of Early-Onset Dementia with Negative Family History: Implications from Two Cases of Early-Onset Alzheimer's Disease with De Novo PSEN1 Mutation. J. Alzheimers Dis. 2019;68 (2):551-558. doi: 10.3233/JAD-181108. PubMed PMID:30814350 .
  34. Oh, J, Ontaneda, D, Azevedo, C, Klawiter, EC, Absinta, M, Arnold, DL et al.. Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS. Neurology. 2019;92 (11):519-533. doi: 10.1212/WNL.0000000000007099. PubMed PMID:30787160 PubMed Central PMC6511106.
  35. Sheynin, Y, Chamoun, M, Baldwin, AS, Rosa-Neto, P, Hess, RF, Vaucher, E et al.. Cholinergic Potentiation Alters Perceptual Eye Dominance Plasticity Induced by a Few Hours of Monocular Patching in Adults. Front Neurosci. 2019;13 :22. doi: 10.3389/fnins.2019.00022. PubMed PMID:30766471 PubMed Central PMC6365463.
  36. Chhetri, JK, Chan, P, Vellas, B, Touchon, J, Gauthier, S. Report from the First Clinical Trials on Alzheimer's Disease (CTAD) Asia-China 2018 : Bringing together Global Leaders. J Prev Alzheimers Dis. 2019;6 (2):144-147. doi: 10.14283/jpad.2019.2. PubMed PMID:30756122 .
  37. Gordon, BA, Blazey, TM, Christensen, J, Dincer, A, Flores, S, Keefe, S et al.. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers. Brain. 2019;142 (4):1063-1076. doi: 10.1093/brain/awz019. PubMed PMID:30753379 PubMed Central PMC6439328.
  38. Uribe, CF, Mathotaarachchi, S, Gaudet, V, Smith, KC, Rosa-Neto, P, Bénard, F et al.. Machine Learning in Nuclear Medicine: Part 1-Introduction. J. Nucl. Med. 2019;60 (4):451-458. doi: 10.2967/jnumed.118.223495. PubMed PMID:30733322 .
  39. Reisberg, B, Torossian, C, Shulman, MB, Monteiro, I, Boksay, I, Golomb, J et al.. Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment). J. Alzheimers Dis. 2019;67 (2):685-705. doi: 10.3233/JAD-180341. PubMed PMID:30689585 .
  40. Thorogood, A, Mäki-Petäjä-Leinonen, A, Dalpé, G, Gastmans, C, Gauthier, S. Openness, inclusion, and respect in dementia research. Lancet Neurol. 2019;18 (2):135-136. doi: 10.1016/S1474-4422(18)30445-9. PubMed PMID:30663603 .
  41. Jiang, L, Oualkacha, K, Didelez, V, Ciampi, A, Rosa-Neto, P, Benedet, AL et al.. Constrained instruments and their application to Mendelian randomization with pleiotropy. Genet. Epidemiol. 2019;43 (4):373-401. doi: 10.1002/gepi.22184. PubMed PMID:30635941 PubMed Central PMC6537099.
  42. Carter, SF, Herholz, K, Rosa-Neto, P, Pellerin, L, Nordberg, A, Zimmer, ER et al.. Astrocyte Biomarkers in Alzheimer's Disease. Trends Mol Med. 2019;25 (2):77-95. doi: 10.1016/j.molmed.2018.11.006. PubMed PMID:30611668 .
  43. Schirrmacher, R, Bailey, JJ, Mossine, AV, Scott, PJH, Kaiser, L, Bartenstein, P et al.. Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging. Pharmaceuticals (Basel). 2019;12 (1):. doi: 10.3390/ph12010007. PubMed PMID:30609832 PubMed Central PMC6469173.
  44. Lam, J, DuBois, JM, Rowley, J, González-Otárula, KA, Soucy, JP, Massarweh, G et al.. In vivo metabotropic glutamate receptor type 5 abnormalities localize the epileptogenic zone in mesial temporal lobe epilepsy. Ann. Neurol. 2019;85 (2):218-228. doi: 10.1002/ana.25404. PubMed PMID:30597619 .
  45. Benz, A, Meier, M, Mankin, M, Unternaehrer, E, Pruessner, JC. The duration of the cortisol awakening pulse exceeds sixty minutes in a meaningful pattern. Psychoneuroendocrinology. 2019;105 :187-194. doi: 10.1016/j.psyneuen.2018.12.225. PubMed PMID:30595408 .
  46. Nitschke, JP, Chu, S, Pruessner, JC, Bartz, JA, Sheldon, S. Post-learning stress reduces the misinformation effect: effects of psychosocial stress on memory updating. Psychoneuroendocrinology. 2019;102 :164-171. doi: 10.1016/j.psyneuen.2018.12.008. PubMed PMID:30562688 .
  47. Hopewell, R, Ross, K, Kostikov, A, Pascoal, TA, Alberti, T, Lacatus-Samoila, M et al.. A simplified radiosynthesis of [18 F]MK-6240 for tau PET imaging. J Labelled Comp Radiopharm. 2019;62 (2):109-114. doi: 10.1002/jlcr.3695. PubMed PMID:30426529 .
  48. Schilling, LP, Pascoal, TA, Zimmer, ER, Mathotaarachchi, S, Shin, M, de Mello Rieder, CR et al.. Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia. Mol. Neurobiol. 2019;56 (7):4916-4924. doi: 10.1007/s12035-018-1405-1. PubMed PMID:30414086 .
  49. Hu, X, Wang, Y, Pruessner, JC, Yang, J. Interdependent self-construal, social evaluative threat and subjective, cardiovascular and neuroendocrine stress response in Chinese. Horm Behav. 2018;106 :112-121. doi: 10.1016/j.yhbeh.2018.10.006. PubMed PMID:30336123 .
  50. Zhang, H, Ng, KP, Therriault, J, Kang, MS, Pascoal, TA, Rosa-Neto, P et al.. Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease. Transl Neurodegener. 2018;7 :23. doi: 10.1186/s40035-018-0127-7. PubMed PMID:30311914 PubMed Central PMC6161434.
  51. Thorogood, A, Mäki-Petäjä-Leinonen, A, Brodaty, H, Dalpé, G, Gastmans, C, Gauthier, S et al.. Consent recommendations for research and international data sharing involving persons with dementia. Alzheimers Dement. 2018;14 (10):1334-1343. doi: 10.1016/j.jalz.2018.05.011. PubMed PMID:30293575 .
  52. Ng, KP, Chiew, HJ, Lim, L, Rosa-Neto, P, Kandiah, N, Gauthier, S et al.. The influence of language and culture on cognitive assessment tools in the diagnosis of early cognitive impairment and dementia. Expert Rev Neurother. 2018;18 (11):859-869. doi: 10.1080/14737175.2018.1532792. PubMed PMID:30286681 .
  53. Gauthier, S, Melvin, L, Mylopoulos, M, Abdullah, N. Resident and attending perceptions of direct observation in internal medicine: a qualitative study. Med Educ. 2018;52 (12):1249-1258. doi: 10.1111/medu.13680. PubMed PMID:30276856 .
  54. Xavier, J, Gauthier, S, Cohen, D, Zahoui, M, Chetouani, M, Villa, F et al.. Interpersonal Synchronization, Motor Coordination, and Control Are Impaired During a Dynamic Imitation Task in Children With Autism Spectrum Disorder. Front Psychol. 2018;9 :1467. doi: 10.3389/fpsyg.2018.01467. PubMed PMID:30233439 PubMed Central PMC6129607.
  55. Soe, WH, Durand, C, Guillermet, O, Gauthier, S, de Rouville, HJ, Srivastava, S et al.. Surface manipulation of a curved polycyclic aromatic hydrocarbon-based nano-vehicle molecule equipped with triptycene wheels. Nanotechnology. 2018;29 (49):495401. doi: 10.1088/1361-6528/aae0d9. PubMed PMID:30207539 .
  56. Gagnon, K, Baril, AA, Montplaisir, J, Carrier, J, Chami, S, Gauthier, S et al.. Detection of mild cognitive impairment in middle-aged and older adults with obstructive sleep apnoea. Eur. Respir. J. 2018;52 (5):. doi: 10.1183/13993003.01137-2018. PubMed PMID:30190270 .
  57. Zhang, H, Therriault, J, Kang, MS, Ng, KP, Pascoal, TA, Rosa-Neto, P et al.. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease. Alzheimers Res Ther. 2018;10 (1):80. doi: 10.1186/s13195-018-0407-6. PubMed PMID:30115118 PubMed Central PMC6097333.
  58. Portier, J, Gauthier, S, Cyr, G, Bergeron, Y. Does time since fire drive live aboveground biomass and stand structure in low fire activity boreal forests? Impacts on their management. J. Environ. Manage. 2018;225 :346-355. doi: 10.1016/j.jenvman.2018.07.100. PubMed PMID:30103137 .
  59. Gauthier, S, Herrmann, N, Rosa-Neto, P. Optimal use of cholinergic drugs in Alzheimer's disease. Brain. 2018;141 (9):e68. doi: 10.1093/brain/awy204. PubMed PMID:30084978 .
  60. Pascoal, TA, Shin, M, Kang, MS, Chamoun, M, Chartrand, D, Mathotaarachchi, S et al.. In vivo quantification of neurofibrillary tangles with [18F]MK-6240. Alzheimers Res Ther. 2018;10 (1):74. doi: 10.1186/s13195-018-0402-y. PubMed PMID:30064520 PubMed Central PMC6069775.
  61. Guadagno, A, Kang, MS, Devenyi, GA, Mathieu, AP, Rosa-Neto, P, Chakravarty, M et al.. Reduced resting-state functional connectivity of the basolateral amygdala to the medial prefrontal cortex in preweaning rats exposed to chronic early-life stress. Brain Struct Funct. 2018;223 (8):3711-3729. doi: 10.1007/s00429-018-1720-3. PubMed PMID:30032360 .
  62. Zandifar, A, Fonov, VS, Pruessner, JC, Collins, DL, Alzheimer's Disease Neuroimaging Initiative. The EADC-ADNI harmonized protocol for hippocampal segmentation: A validation study. Neuroimage. 2018;181 :142-148. doi: 10.1016/j.neuroimage.2018.06.077. PubMed PMID:29966720 .
  63. Jia, J, Wei, C, Chen, S, Li, F, Tang, Y, Qin, W et al.. Efficacy and safety of the compound Chinese medicine SaiLuoTong in vascular dementia: A randomized clinical trial. Alzheimers Dement (N Y). 2018;4 :108-117. doi: 10.1016/j.trci.2018.02.004. PubMed PMID:29955654 PubMed Central PMC6021260.
  64. Zukotynski, K, Kuo, PH, Mikulis, D, Rosa-Neto, P, Strafella, AP, Subramaniam, RM et al.. PET/CT of Dementia. AJR Am J Roentgenol. 2018;211 (2):246-259. doi: 10.2214/AJR.18.19822. PubMed PMID:29949415 .
  65. Wu, LY, Zhan, SQ, Huang, ZY, Zhang, B, Wang, T, Liu, CF et al.. Expert Consensus on Clinical Diagnostic Criteria for Fatal Familial Insomnia. Chin. Med. J. 2018;131 (13):1613-1617. doi: 10.4103/0366-6999.235115. PubMed PMID:29941716 PubMed Central PMC6032681.
  66. Smart, K, Cox, SML, Nagano-Saito, A, Rosa-Neto, P, Leyton, M, Benkelfat, C et al.. Test-retest variability of [11 C]ABP688 estimates of metabotropic glutamate receptor subtype 5 availability in humans. Synapse. 2018;72 (9):e22041. doi: 10.1002/syn.22041. PubMed PMID:29935121 .
  67. Gröpel, P, Urner, M, Pruessner, JC, Quirin, M. Endurance- and Resistance-Trained Men Exhibit Lower Cardiovascular Responses to Psychosocial Stress Than Untrained Men. Front Psychol. 2018;9 :852. doi: 10.3389/fpsyg.2018.00852. PubMed PMID:29910757 PubMed Central PMC5992644.
  68. Gauthier, S, Anzalone, SM, Cohen, D, Zaoui, M, Chetouani, M, Villa, F et al.. Behavioral Own-Body-Transformations in Children and Adolescents With Typical Development, Autism Spectrum Disorder, and Developmental Coordination Disorder. Front Psychol. 2018;9 :676. doi: 10.3389/fpsyg.2018.00676. PubMed PMID:29887813 PubMed Central PMC5981221.
  69. Gauthier, S, Zhang, H, Ng, KP, Pascoal, TA, Rosa-Neto, P. Impact of the biological definition of Alzheimer's disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?. Transl Neurodegener. 2018;7 :12. doi: 10.1186/s40035-018-0117-9. PubMed PMID:29876101 PubMed Central PMC5977549.
  70. Sheldon, S, Chu, S, Nitschke, JP, Pruessner, JC, Bartz, JA. The dynamic interplay between acute psychosocial stress, emotion and autobiographical memory. Sci Rep. 2018;8 (1):8684. doi: 10.1038/s41598-018-26890-8. PubMed PMID:29875390 PubMed Central PMC5989264.
  71. Khachaturian, AS, Hayden, KM, Mielke, MM, Tang, Y, Lutz, MW, Gold, M et al.. New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia. Alzheimers Dement. 2018;14 (6):703-706. doi: 10.1016/j.jalz.2018.05.002. PubMed PMID:29842864 .
  72. Dubois, MA, Guillermet, O, Gauthier, S, Zhan, G, Makoudi, Y, Palmino, F et al.. Influence of Cu adatoms on the molecular assembly of 4,4'-bipyridine on Cu(111). Phys Chem Chem Phys. 2018;20 (22):15350-15357. doi: 10.1039/c8cp01184b. PubMed PMID:29796573 .
  73. Freshwater, C, Trudel, M, Beacham, TD, Gauthier, S, Johnson, SC, Neville, CE et al.. Individual variation, population-specific behaviours and stochastic processes shape marine migration phenologies. J Anim Ecol. 2019;88 (1):67-78. doi: 10.1111/1365-2656.12852. PubMed PMID:29790171 .
  74. Gauthier, S, LeBlanc, J, Seresova, A, Laberge-Poirier, A, A Correa, J, Alturki, AY et al.. Acute prediction of outcome and cognitive-communication impairments following traumatic brain injury: The influence of age, education and site of lesion. J Commun Disord. ;73 :77-90. doi: 10.1016/j.jcomdis.2018.04.003. PubMed PMID:29709658 .
  75. Meyer, PF, Savard, M, Poirier, J, Labonté, A, Rosa-Neto, P, Weitz, TM et al.. Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis. J. Alzheimers Dis. 2018;63 (2):577-590. doi: 10.3233/JAD-170887. PubMed PMID:29660934 PubMed Central PMC5929310.
  76. Boucher, D, Boulanger, Y, Aubin, I, Bernier, PY, Beaudoin, A, Guindon, L et al.. Current and projected cumulative impacts of fire, drought, and insects on timber volumes across Canada. Ecol Appl. 2018;28 (5):1245-1259. doi: 10.1002/eap.1724. PubMed PMID:29645330 .
  77. Christopher, MS, Hunsinger, M, Goerling, LRJ, Bowen, S, Rogers, BS, Gross, CR et al.. Mindfulness-based resilience training to reduce health risk, stress reactivity, and aggression among law enforcement officers: A feasibility and preliminary efficacy trial. Psychiatry Res. 2018;264 :104-115. doi: 10.1016/j.psychres.2018.03.059. PubMed PMID:29627695 PubMed Central PMC6226556.
  78. Gauthier, S, Ng, KP, Pascoal, TA, Zhang, H, Rosa-Neto, P. Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment. J. Alzheimers Dis. 2018;64 (s1):S23-S31. doi: 10.3233/JAD-179924. PubMed PMID:29504543 PubMed Central PMC6004905.
  79. Villeneuve, S, Vogel, JW, Gonneaud, J, Pichet Binette, A, Rosa-Neto, P, Gauthier, S et al.. Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease. JAMA Neurol. 2018;75 (5):608-619. doi: 10.1001/jamaneurol.2017.5135. PubMed PMID:29482212 PubMed Central PMC5885216.
  80. Schoemaker, D, Buss, C, Head, K, Sandman, CA, Davis, EP, Chakravarty, MM et al.. Corrigendum to "Hippocampus and amygdala volumes from magnetic resonance images in children: Assessing accuracy of FreeSurfer and FSL against manual segmentation"[NeuroImage 129 (2016) 1-14]. Neuroimage. 2018;173 :1-2. doi: 10.1016/j.neuroimage.2018.02.009. PubMed PMID:29477029 .
  81. Benedet, AL, Yu, L, Labbe, A, Mathotaarachchi, S, Pascoal, TA, Shin, M et al.. CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem. Neurol Genet. 2018;4 (1):e216. doi: 10.1212/NXG.0000000000000216. PubMed PMID:29473050 PubMed Central PMC5820598.
  82. Durand, RJ, Gauthier, S, Achelle, S, Groizard, T, Kahlal, S, Saillard, JY et al.. Push-pull D-π-Ru-π-A chromophores: synthesis and electrochemical, photophysical and second-order nonlinear optical properties. Dalton Trans. 2018;47 (11):3965-3975. doi: 10.1039/c8dt00093j. PubMed PMID:29464264 .
  83. Mortby, ME, Black, SE, Gauthier, S, Miller, D, Porsteinsson, A, Smith, EE et al.. Dementia clinical trial implications of mild behavioral impairment. Int Psychogeriatr. 2018;30 (2):171-175. doi: 10.1017/S1041610218000042. PubMed PMID:29448970 .
  84. Therriault, J, Ng, KP, Pascoal, TA, Mathotaarachchi, S, Kang, MS, Struyfs, H et al.. Anosognosia predicts default mode network hypometabolism and clinical progression to dementia. Neurology. 2018;90 (11):e932-e939. doi: 10.1212/WNL.0000000000005120. PubMed PMID:29444971 PubMed Central PMC5858945.
  85. Jia, J, Wei, C, Chen, S, Li, F, Tang, Y, Qin, W et al.. The cost of Alzheimer's disease in China and re-estimation of costs worldwide. Alzheimers Dement. 2018;14 (4):483-491. doi: 10.1016/j.jalz.2017.12.006. PubMed PMID:29433981 .
  86. Pascoal, TA, Mathotaarachchi, S, Shin, M, Park, AY, Mohades, S, Benedet, AL et al.. Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging. 2018;45 (6):1021-1030. doi: 10.1007/s00259-018-3933-3. PubMed PMID:29396637 PubMed Central PMC5915512.
  87. Hellhammer, D, Meinlschmidt, G, Pruessner, JC. Conceptual endophenotypes: A strategy to advance the impact of psychoneuroendocrinology in precision medicine. Psychoneuroendocrinology. 2018;89 :147-160. doi: 10.1016/j.psyneuen.2017.12.009. PubMed PMID:29396321 .
  88. Belleville, S, Hudon, C, Bier, N, Brodeur, C, Gilbert, B, Grenier, S et al.. MEMO+: Efficacy, Durability and Effect of Cognitive Training and Psychosocial Intervention in Individuals with Mild Cognitive Impairment. J Am Geriatr Soc. 2018;66 (4):655-663. doi: 10.1111/jgs.15192. PubMed PMID:29313875 .
  89. Henriques, AD, Benedet, AL, Camargos, EF, Rosa-Neto, P, Nóbrega, OT. Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to. Exp. Gerontol. 2018;107 :169-177. doi: 10.1016/j.exger.2018.01.002. PubMed PMID:29307736 .
  90. Shakra, MA, Leyton, M, Moghnieh, H, Pruessner, J, Dagher, A, Pihl, R et al.. Neurobiological Correlates and Predictors of Two Distinct Personality Trait Pathways to Escalated Alcohol Use. EBioMedicine. 2018;27 :86-93. doi: 10.1016/j.ebiom.2017.11.025. PubMed PMID:29292030 PubMed Central PMC5828056.
  91. Thorn, S, Bässler, C, Brandl, R, Burton, PJ, Cahall, R, Campbell, JL et al.. Impacts of salvage logging on biodiversity: a meta-analysis. J Appl Ecol. 2018;55 (1):279-289. doi: 10.1111/1365-2664.12945. PubMed PMID:29276308 PubMed Central PMC5736105.
  92. Bernard-Gauthier, V, Mossine, AV, Mahringer, A, Aliaga, A, Bailey, JJ, Shao, X et al.. Identification of [18F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET Imaging. J. Med. Chem. 2018;61 (4):1737-1743. doi: 10.1021/acs.jmedchem.7b01607. PubMed PMID:29257860 .
  93. Sinyavskaya, L, Gauthier, S, Renoux, C, Dell'Aniello, S, Suissa, S, Brassard, P et al.. Comparative effect of statins on the risk of incident Alzheimer disease. Neurology. 2018;90 (3):e179-e187. doi: 10.1212/WNL.0000000000004818. PubMed PMID:29247073 .
  94. Kogler, L, Seidel, EM, Metzler, H, Thaler, H, Boubela, RN, Pruessner, JC et al.. Impact of self-esteem and sex on stress reactions. Sci Rep. 2017;7 (1):17210. doi: 10.1038/s41598-017-17485-w. PubMed PMID:29222516 PubMed Central PMC5722874.
  95. Aisen, P, Touchon, J, Amariglio, R, Andrieu, S, Bateman, R, Breitner, J et al.. EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials. J Prev Alzheimers Dis. 2017;4 (2):116-124. doi: 10.14283/jpad.2017.13. PubMed PMID:29186281 PubMed Central PMC5724787.
  96. Kahle-Wrobleski, K, Andrews, JS, Belger, M, Ye, W, Gauthier, S, Rentz, DM et al.. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study. J Prev Alzheimers Dis. 2017;4 (2):72-80. doi: 10.14283/jpad.2017.2. PubMed PMID:29186278 PubMed Central PMC5912689.
  97. Abushakra, S, Porsteinsson, A, Scheltens, P, Sadowsky, C, Vellas, B, Cummings, J et al.. Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential. J Prev Alzheimers Dis. 2017;4 (3):149-156. doi: 10.14283/jpad.2017.26. PubMed PMID:29182706 .
  98. Tardif, CL, Devenyi, GA, Amaral, RSC, Pelleieux, S, Poirier, J, Rosa-Neto, P et al.. Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease. Hum Brain Mapp. 2018;39 (2):971-984. doi: 10.1002/hbm.23897. PubMed PMID:29164798 .
  99. Li, X, Ba, M, Ng, KP, Mathotaarachchi, S, Pascoal, TA, Rosa-Neto, P et al.. Characterizing biomarker features of cognitively normal individuals with ventriculomegaly. Alzheimers Dement (Amst). 2018;10 :12-21. doi: 10.1016/j.dadm.2017.08.001. PubMed PMID:29159265 PubMed Central PMC5678356.
  100. Wilcock, GK, Gauthier, S, Frisoni, GB, Jia, J, Hardlund, JH, Moebius, HJ et al.. Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial. J. Alzheimers Dis. 2018;61 (1):435-457. doi: 10.3233/JAD-170560. PubMed PMID:29154277 PubMed Central PMC5734125.
Search PubMed